Does VINORELBINE Cause Interstitial lung disease? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Interstitial lung disease have been filed in association with VINORELBINE (Vinorelbine). This represents 1.1% of all adverse event reports for VINORELBINE.
55
Reports of Interstitial lung disease with VINORELBINE
1.1%
of all VINORELBINE reports
8
Deaths
15
Hospitalizations
How Dangerous Is Interstitial lung disease From VINORELBINE?
Of the 55 reports, 8 (14.5%) resulted in death, 15 (27.3%) required hospitalization, and 5 (9.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINORELBINE. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does VINORELBINE Cause?
Off label use (644)
Malignant neoplasm progression (624)
Disease progression (526)
Neutropenia (517)
Nausea (504)
Drug ineffective (391)
Fatigue (373)
Diarrhoea (371)
Vomiting (342)
Anaemia (335)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which VINORELBINE Alternatives Have Lower Interstitial lung disease Risk?
VINORELBINE vs VINORELBINE\VINORELBINE
VINORELBINE vs VIREAD
VINORELBINE vs VISIPAQUE
VINORELBINE vs VISMODEGIB
VINORELBINE vs VITAMIN A